$5.33
+0.06
(+1.14%)▲
2.63%
Downside
Day's Volatility :4.07%
Upside
1.48%
8.44%
Downside
52 Weeks Volatility :57.23%
Upside
53.29%
Period | Docgo Inc | |
---|---|---|
3 Months | -43.12% | |
6 Months | -37.95% | |
1 Year | -46.88% | |
3 Years | -29.73% |
Market Capitalization | 907.1M |
Book Value | $2.7 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | 0.06 |
PE Ratio | 145.67 |
Wall Street Target Price | 13.57 |
Profit Margin | 1.27% |
Operating Margin TTM | 0.15% |
Return On Assets TTM | 0.12% |
Return On Equity TTM | 2.62% |
Revenue TTM | 451.6M |
Revenue Per Share TTM | 4.4 |
Quarterly Revenue Growth YOY | 14.6% |
Gross Profit TTM | 154.7M |
EBITDA | 14.5M |
Diluted Eps TTM | 0.06 |
Quarterly Earnings Growth YOY | -0.51 |
EPS Estimate Current Year | 0.08 |
EPS Estimate Next Year | 0.35 |
EPS Estimate Current Quarter | 0.03 |
EPS Estimate Next Quarter | 0.08 |
What analysts predicted
Upside of 154.6%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 48.3M | - |
Net Income | -20.2M | - |
Net Profit Margin | -41.84% | - |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 94.1M | ↑ 94.81% |
Net Income | -14.4M | ↓ 28.95% |
Net Profit Margin | -15.26% | ↑ 26.58% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 94.1M | ↑ 0.0% |
Net Income | -14.4M | ↑ 0.0% |
Net Profit Margin | -15.26% | ↑ 0.0% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 440.5M | ↑ 368.18% |
Net Income | 34.6M | ↓ 340.84% |
Net Profit Margin | 7.85% | ↑ 23.11% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 117.9M | ↓ 2.83% |
Net Income | 10.6M | ↓ 54.88% |
Net Profit Margin | 9.02% | ↓ 10.4% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 109.5M | ↓ 7.1% |
Net Income | 12.7M | ↑ 19.81% |
Net Profit Margin | 11.63% | ↑ 2.61% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 104.3M | ↓ 4.75% |
Net Income | 3.2M | ↓ 75.23% |
Net Profit Margin | 3.02% | ↓ 8.61% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 108.8M | ↑ 4.28% |
Net Income | 8.1M | ↑ 155.66% |
Net Profit Margin | 7.41% | ↑ 4.39% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 125.5M | - |
Net Income | -2.0M | ↓ 41.97% |
Net Profit Margin | -1.6% | - |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 101.0M | - |
Total Liabilities | 21.6M | - |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 100.2M | ↓ 0.78% |
Total Liabilities | 33.2M | ↑ 53.81% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 100.2M | ↑ 0.0% |
Total Liabilities | 33.2M | ↑ 0.0% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 393.3M | ↑ 292.6% |
Total Liabilities | 114.4M | ↑ 244.17% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 325.2M | ↑ 5.04% |
Total Liabilities | 84.9M | ↑ 2.89% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 331.9M | ↑ 2.05% |
Total Liabilities | 77.5M | ↓ 8.8% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 355.9M | ↑ 7.25% |
Total Liabilities | 85.1M | ↑ 9.84% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 393.3M | ↑ 10.5% |
Total Liabilities | 114.4M | ↑ 34.39% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 407.5M | ↑ 3.63% |
Total Liabilities | 123.6M | ↑ 8.11% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 390.3M | ↓ 4.23% |
Total Liabilities | 106.4M | ↓ 13.91% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -14.2M | - |
Investing Cash Flow | -3.0M | - |
Financing Cash Flow | 56.3M | - |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -10.7M | ↓ 25.0% |
Investing Cash Flow | -6.0M | ↑ 103.28% |
Financing Cash Flow | -812.1K | ↓ 101.44% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -10.7M | ↑ 0.0% |
Investing Cash Flow | -8.6M | ↑ 42.2% |
Financing Cash Flow | -812.1K | ↑ 0.0% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 18.3M | ↓ 307.54% |
Investing Cash Flow | -1.1M | ↓ 72.92% |
Financing Cash Flow | 2.5M | ↓ 98.33% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 11.9M | ↓ 34.72% |
Investing Cash Flow | -821.0K | ↓ 27.79% |
Financing Cash Flow | -1.4M | ↓ 155.05% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 7.4M | ↓ 37.76% |
Investing Cash Flow | -35.8M | ↑ 4264.67% |
Financing Cash Flow | -436.4K | ↓ 68.25% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 28.9M | ↑ 289.05% |
Investing Cash Flow | -654.0K | ↓ 98.18% |
Financing Cash Flow | -6.2M | ↑ 1316.03% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -23.1M | ↓ 180.08% |
Investing Cash Flow | -1.7M | ↑ 158.33% |
Financing Cash Flow | -12.0M | ↑ 93.39% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 10.7M | ↓ 146.25% |
Investing Cash Flow | -23.7M | ↑ 1304.44% |
Financing Cash Flow | 8.8M | ↓ 173.3% |
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Docgo Inc | -40.25% | -37.95% | -46.88% | -29.73% | -29.73% |
![]() Fresenius Medical Care Ag & Co. Kgaa | -10.75% | 2.65% | 55.16% | -48.95% | -58.99% |
![]() Hca Holdings, Inc. | -10.41% | -3.39% | 36.38% | 101.03% | 78.65% |
![]() Universal Health Services Inc. | -6.87% | 0.58% | 43.8% | 18.48% | -1.47% |
![]() Davita Healthcare Partners Inc. | -8.5% | 19.09% | 16.35% | 12.43% | 30.06% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Docgo Inc | 145.67 | 145.67 | NA | 0.08 | 0.03 | 0.0 | 0.0 | 2.7 |
![]() Fresenius Medical Care Ag & Co. Kgaa | 20.39 | 20.39 | 1.06 | 1.99 | 0.05 | 0.03 | 0.03 | 23.05 |
![]() Hca Holdings, Inc. | 12.21 | 12.21 | 1.37 | 18.44 | 0.21 | 0.11 | 0.01 | -8.44 |
![]() Universal Health Services Inc. | 12.92 | 12.92 | 1.87 | 10.19 | 0.11 | 0.05 | 0.01 | 87.72 |
![]() Davita Healthcare Partners Inc. | 19.34 | 19.34 | 0.86 | 7.21 | 0.29 | 0.05 | 0.0 | 11.15 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Docgo Inc | Buy | $907.1M | -29.73% | 145.67 | 1.27% |
![]() Fresenius Medical Care Ag & Co. Kgaa | Hold | $12.8B | -58.99% | 20.39 | 3.04% |
![]() Hca Holdings, Inc. | Buy | $67.3B | 78.65% | 12.21 | 9.32% |
![]() Universal Health Services Inc. | Hold | $8.6B | -1.47% | 12.92 | 5.02% |
![]() Davita Healthcare Partners Inc. | Hold | $8.8B | 30.06% | 19.34 | 3.98% |
BlackRock Inc
Hood River Capital Management LLC
Vanguard Group Inc
Deerfield Management Co
Portolan Capital Management, LLC
Emerald Advisers, LLC
DocGo is a leading provider of mobile medical services and transportation in 26 US States and in the United Kingdom.
Organization | Docgo Inc |
Employees | 2064 |
CEO | Mr. Stan Vashovsky |
Industry | Transportation |